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ABSTRACT
Brefeldin A resistance factor 1 (Bfr1p) is a nonessential RNA-binding protein and multicopy suppressor of brefeldin A
sensitivity in Saccharomyces cerevisiae. Deletion of BFR1 leads to multiple defects, including altered cell shape and
size, change in ploidy, induction of P-bodies and chromosomal missegregation. Bfr1p has been shown to associate with
polysomes, binds to several hundred mRNAs, and can target some of them to P-bodies. Although this implies a role of
Bfr1p in translational control of mRNAs, its molecular function remains elusive. In the present study, we show that muta-
tions in RNA-binding residues of Bfr1p impede its RNA-dependent colocalization with ER, yet do not mimic the known cel-
lular defects seen upon BFR1 deletion. However, a Bfr1 RNA-binding mutant is impaired in binding to ERG4mRNA, which
encodes an enzyme required for the final step of ergosterol biosynthesis. Consistently, bfr1Δ strains show a strong reduc-
tion in Erg4p protein levels, most likely because of degradation of misfolded Erg4p. Polysome profiling of bfr1Δ or bfr1
mutant strains reveals a strong shift of ERG4 mRNA to polysomes, consistent with a function of Bfr1p in elongation or in-
creased ribosome loading. Collectively, our data reveal that Bfr1 has at least two separable functions: one in RNA binding
and cotranslational protein translocation into the ER and one in ploidy control or chromosome segregation.
Keywords: RNA-binding protein; yeast; endoplasmic reticulum; brefeldin A resistance; ribosomal occupancy; RNA-protein
interaction
INTRODUCTION
Function and lifetime of mRNAs are largely controlled
by RNA-binding proteins (RBPs) that can regulate RNA
folding, stability, translation, localization, or access by oth-
er proteins (Dreyfuss et al. 2002; Lunde et al. 2007; Björk
and Wieslander 2017; Neriec and Percipalle 2018).
These proteins can bind RNA cotranscriptionally at birth
and dynamically associate/dissociate throughout the life-
time of mRNAs. RNA recognition and binding generally
occurs via RNA-binding domains (RBDs). Common RBDs
include the RNA recognition motif (RRM; Oubridge et al.
1994), the heterologous nuclear RBP K homology (KH)
domain (Lewis et al. 2000), the double-stranded RNA-
binding domain (dsRBD; Ryter and Schultz 1998), or zinc-
finger domains (Lu et al. 2003); for a detailed and more
complete list, see Auweter et al. (2006) and Lunde et al.
(2007). However, high-throughput RNA-binding studies
have revealed a large number of RBPs lacking known
RBDs, implicating the presence of even more RBPs than
previously anticipated (Baltz et al. 2012; Castello et al.
2012, 2015; Kwon et al. 2013; Beckmann et al. 2015;
Hentze et al. 2018). RNA binding of these proteins fre-
quently occurs via intrinsically disordered regions (IDRs;
Hentze et al. 2018) or nucleotide-binding sites (Castello
et al. 2015, 2016). Many of these proteins, like some en-
zymes, have functions additional to RNA binding. Further-
more, in many cases, we do not know the biological
function of RNA binding or even their RNA targets.
The 55-kDa budding yeast Bfr1 protein is a nonessential
RBP lacking common RBDs. The gene had been originally
identified in a screen for genes relieving the growth defect
seen in yeast cells carrying a mutation in SEC21 if exposed
to the drug brefeldin A (Jackson and Képès 1994) and
hence named brefeldin A resistance factor 1 (BFR1).
Because brefeldin A inhibits transport out of the Golgi ap-
paratus, this early work suggested that Bfr1p is involved in
membrane trafficking (Jackson and Képès 1994). However,
later studies revealed a role for Bfr1p in mRNAmetabolism
(Lang et al. 2001). Bfr1p cofractionates with polysomes,
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implying a function in translation. In addition, it associates
with RNA–protein particles (RNPs) that contain the mRNA-
binding protein Scp160p (Lang and Fridovich-Keil 2000)
and the ribosome-associated protein Asc1p (Sezen et al.
2009). Copurification of Bfr1p with mRNPs is independent
of Scp160p, but Bfr1p is required for Scp160p’s associa-
tion with polysomes (Lang et al. 2001). Consistent with
its putative role in translation, Bfr1p is present in the cyto-
plasm but also localizes to the endoplasmic reticulum (ER),
possibly because of its interaction with polyribosomes
translating membrane or secreted proteins (Lang et al.
2001).
Potential RNA targets of Bfr1p have been revealed in
several studies using RBP immunoprecipitation coupled
with microarray analysis (RIP-Chip; Hogan et al. 2008),
cross-linking and immunoprecipitation (CLIP; Mitchell
et al. 2013), or RNA tagging (Lapointe et al. 2015). All
studies concurrently reported that Bfr1p binds to several
hundred different mRNAs. The set of Bfr1p-associated
mRNAs largely overlaps with those that encode proteins
translated at the ER (Jan et al. 2014; Lapointe et al.
2015). A similar observation had been made for Scp160p
(Hogan et al. 2008; Lapointe et al. 2015), supporting the
idea that the protein is implicated in ER-based translation.
In addition, Bfr1p functions in stress-related mRNA de-
cay. During glucose depletion, Bfr1p relocates to P-bodies
at a late stage of P-body formation (Simpson et al. 2014). It
is also required for targeting of mRNAs to P-bodies at a
late phase of stress. In unstressed cells, Bfr1p and
Scp160 act as negative regulators of P-body formation,
probably by protecting mRNA at polysomes (Weidner
et al. 2014). Lack of any of these proteins results in
P-body-like structures even under optimal growth condi-
tions (Weidner et al. 2014). Loss of Bfr1p additionally leads
to changes in the cell ploidy (Jackson and Képès 1994).
Such ploidy changes could be the result of chromosome
missegregation due to a failure to build a functional mitotic
bipolar spindle. Monopolar spindles can arise fromdefects
in spindle pole body (SPB) duplication, and the SPB com-
ponent Bbp1p has been reported to bind to Bfr1p (Xue
et al. 1996). In addition, Bfr1p interacts with the SESA
(Smy2-Eap1-Scp160-Asc1) network that controls spindle
pole duplication (Sezen et al. 2009).
All previous studies that reported on phenotypes associ-
ated with loss of Bfr1p were performed with BFR1 deletion
cells. Because the loss of Bfr1p results in alterations of the
genome (Jackson and Képès 1994), it remained unclear if
the observed effects are a direct consequence of Bfr1p
loss and to what extent loss of RNA binding or misregula-
tion of Bfr1p targets contribute to the phenotypes.
Therefore, we generated Bfr1p mutants with point muta-
tions in known RNA-binding sites in order to establish a
link betweenmRNA binding, brefeldin A resistance, ploidy
control, and translation. Here, we demonstrate that RNA
binding is required for Bfr1p function in translational regu-
lation or protein translocation of ERG4 that encodes an er-
gosterol-synthesizing enzyme, that, in bfr1mutants, Erg4p
becomes a substrate for the ERAD pathway because of its
misfolding, and that RNA-binding of Bfr1p is independent
of its role in ploidy maintenance.
RESULTS
RNA binding of Bfr1p is required for its localization
to the ER
The noncanonical RBP Bfr1p is involved in several cellular
processes including transfer and retention of mRNAs to
P-bodies (Simpson et al. 2014; Weidner et al. 2014), trans-
lation (Lang et al. 2001), and response to functional failure
of the yeast SPB or kinetochore (Sezen et al. 2009; Low
et al. 2014).We generatedbfr1mutants in order to address
the question of whether RNAbinding is required for all pro-
cesses. Because Bfr1p lacks canonical RBDs, we made ala-
nine substitutions at amino acid positions that had
previously been identified to cross-link with RNA in vivo
(Supplemental Fig. S1; Kramer et al. 2014; Lapointe et al.
2015). Out of the six RNA contact sites that have been de-
scribed, we initially focused on the two amino acids (K138,
F239) that are most highly conserved in Bfr1p among dif-
ferent yeast species (Fig. 1A; Supplemental Fig. S1). In ad-
dition, we generated a shorter Bfr1p variant that lacks the
third coiled-coil domain, which is devoid of any identified
RNA contact sites (Kramer et al. 2014). When expressed
as carboxy-terminal GFP fusion proteins in a bfr1Δ yeast
strain, Bfr1p mutant proteins with point mutations in two
cross-link sites (K139 or F293) or in all six sites are ex-
pressed similarly (Fig. 1B,C) as endogenous full-length
Bfr1p (Bfr1p WT FL). Similar results were obtained for the
deletion of mutant Bfr1p(1–397). In exponentially growing
yeast cells, Bfr1p is located in the cytoplasm and at the ER
(Lang et al. 2001), which is recapitulated by our Bfr1-GFP
fusion protein (Fig. 1D,E). Whereas deletion of the third
coiled-coil domain does not affect this distribution, muta-
tion of all six conserved RNA cross-link sites as well as
also the single exchange of F239A results in a partial loss
of Bfr1p from the ER as determined by live-cell imaging
and subcellular fractionation (Fig. 1D,E). The majority of
wild-type Bfr1p cosediments with a membrane fraction
containing ER as judged by the distribution of the ERmark-
er Sec61p (Fig. 1F). Similarly, the signal of Bfr1p(1–397) in
the membrane fraction is also more prominent than in the
cytoplasmic fraction. In contrast, the ratio of Bfr1p between
the membrane and cytoplasmic fraction is inversed for the
bfr1mut6A mutant (Fig. 1F). Out of all single point muta-
tions, F239 is the only cross-link site for which a mutation
affects ER localization. Singlemutations in eachof the other
five sites result in no change in Bfr1p distribution
(Supplemental Fig. S2). To investigate whether the loss of
ER localization of bfr1mut6A and bfr1mutF293A proteins
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is due to loss of RNA binding, we followed the distribution
of wild-type Bfr1p in the subcellular distribution in lysates
treated with RNase A (Fig. 1G). RNA degradation results
in a similar redistribution of Bfr1p from the membrane frac-
tions to a cytosolic fraction—the same as that observed for
the mutant proteins. This suggests that the RNA-binding
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FIGURE 1. Mutations in RNA-binding residues of Bfr1p affects the Bfr1p-ER localization. (A) Schematic view of the Bfr1p constructs used in this
study. All four constructs were fused to a carboxy-terminal yeGFP and integrated into the genomic BFR1 locus. RNA-binding residues R38, H79,
K138, F211, Y225, and F239 were replacedwith alanine, andmutant bfr1mut6A contains all six mutations. Bfr1p(1–397) is a truncation lacking the
third coiled-coil. (B) Equal expression of Bfr1p in various mutants of RNA-binding residues. Total cell lysates from the yeGFP-tagged Bfr1p full-
length (WT FL), Bfr1p(1–397), bfr1mutF239A, bfr1mutK138A, and bfr1mut6Awere analyzed by western blotting. Pgk1p serves as a loading con-
trol. (C ) Quantification of Bfr1p levels. Data displayed as percentage protein levels compared to the wild type from three biological replicates.
Normalization to Pgk1p was performed for each strain before normalization to Bfr1p wild-type levels were made. Error bars show ±SD.
(D) Intracellular distribution of yeGFP-tagged Bfr1p constructs. Plasmid-expressed HDEL-DsRed serves as an ERmarker. Bfr1p variants of mutants
bfr1mutF239A and bfr1mut6A show loss of colocalization between Bfr1p and the ER. Scale bar, 8 µm. (E) Distribution of Bfr1p constructs in sub-
cellular fractionation. (I) input, (M) membrane fraction (pellet from 18,000g), (C) cytoplasmic fraction (supernatant from 18,000g). Pgk1p serves as
cytosolic and Sec61p as ER markers. (F ) Quantification of subcellular fractionation of yeGFP-tagged Bfr1p constructs. Data are displayed as rel-
ative protein levels. Protein in the membrane fraction was normalized to Sec61p and in cytoplasmic fraction to Pgk1p. Results stem from three
biological replicates. Error bars show ±SD. (G) Redistribution of Bfr1p between the membrane and cytosolic fractions upon RNase treatment.
(M6) membrane fraction (pellet from 6000g), (M18) membrane fraction (pellet from 18,000g), and (C) cytoplasmic fraction (supernatant from
18,000g).
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Because deletion ofBFR1 is associatedwith various phe-
notypes, we also tested if bfr1mut6A or bfr1mutF293A af-
fect ploidy maintenance (Jackson and Képès 1994; Xue
et al. 1996), resistance to brefeldin A (Jackson and Képès
1994), or premature formation of P-bodies (Weidner
et al. 2014). As described before, complete loss of BFR1
results in a ploidy shift from 1N to 2N as exemplified by
the shift of DNApeaks from1C/2C (haploid) to 2C/4C (dip-
loid) in flow cytometry analysis (Fig. 2A; Supplemental Fig.
S3). However, a similar shift is not seen in the tested mu-
tants (Fig. 2A). Overexpression of BFR1 has been demon-
strated to rescue the brefeldin A sensitivity of a yeast
mutant lacking the ERG6 gene (Graham et al. 1993; Shah
and Klausner 1993). Because all tested bfr1 point mutants
including mutant bfr1mut6A are still able to rescue erg6Δ
to a similar level as thewild type (Fig. 2B), we conclude that
none of these sites are important for suppression of the
brefeldin A sensitivity in erg6Δ. Similarly, none of the
RNA-bindingmutants lead to the occurrence of premature
P-bodies is observed in bfr1Δ cells. Formation of P-bodies
in wild-type cells or bfr1Δ cells expressing various Bfr1p-
GFP variants was assessed by coexpression of Edc3p-
mCherry, a bona fide P-body marker (Weidner et al.
2014). Formation of Edc3p-positive cytoplasmic foci in
wild-type cells is induced by transferring cells into medium
lacking glucose (Fig. 2C, right panels), a potent inducer of
P-bodies. Whereas bfr1Δ cells form Edc3p foci also in the
presence of glucose, expression of full-length Bfr1p or
Bfr1p RNA-binding mutants rescues this phenotype (Fig.
2C, left panels).
Taken together, point mutations in F239 or the six amino
acids that form cross-links to RNA affect the intracellular
distribution of Bfr1p—in particular, ER localization—but
this ER localization of Bfr1p is not required for ploidy main-
tenance, brefeldin A sensitivity, or P-body formation, indi-
cating that RNA binding might not be required for these
functions of Bfr1p.
Colocalization of the Bfr1p mRNA target ERG4
with ER is independent of Bfr1p
Several hundred mRNAs have been identified that are po-
tential binding partners of Bfr1p and translated at the ER
(Hogan et al. 2008; Mitchell et al. 2013; Lapointe et al.
2015), but it has not yet been addressed how Bfr1p affects
their function. We, therefore, addressed the physiological
changes of potential Bfr1p RNA targets upon mutation of
its RNA contact sites. Because Bfr1p is enriched at the ER
where mRNAs encoding membrane or secreted proteins
are translated,we focusedon fiveBfr1p targets that encode
proteins of these groups and whose functions have been
linked to described phenotypes of bfr1Δ or Bfr1p overex-
pression (Lai et al. 1994; Entian et al. 1999; Zweytick et al.
2000; Beh et al. 2001; Gillingham and Munro 2003; Setty
et al. 2003). These candidates were selected by comparing
the top identified Bfr1p binders from two studies (Hogan
et al. 2008; Lapointe et al. 2015). BasedonBfr1p’s suppres-
sion of the growth inhibition by brefeldin A (Jackson and
Képès 1994), the subsequent selection focused on
mRNAs encoding ER- or Golgi-localized proteins (ERG4,
RUD3, SGM1), proteins involved in ER-Golgi transport
(IMH1), or those involved in sterol biosynthesis (ERG4) or
binding (OSH7). Because the loss of Bfr1p has been linked
to premature P-body formation (Weidner et al. 2014), we
first tested if the loss of BFR1, deletion of the last coiled-
coil domain, or mutations in RNA contact sites affect the
stability of the five selected mRNAs. As judged by qRT-
PCR from total RNA isolates, none of the five tested
mRNAs showed a significant change in their levels (Fig.
3A). We verified whether these mRNAs are bona fide tar-
gets of Bfr1p and whether the introduced mutations of
Bfr1p RNA-binding sites interfere with their binding, and
we investigated two mRNAs, OSH7 and ERG4. We per-
formed coimmunoprecipitation using GFP-tagged ver-
sions of wild-type Bfr1p, bfr1mut6A, and Bfr1p(1–397), as
well as a control RNA-binding GFP fusion protein, Khd1p
(Hasegawa et al. 2008; Syed et al. 2018). MID2, an mRNA
bound by Khd1p (Syed et al. 2018) served as control
mRNA. Only ERG4 mRNA showed an enrichment in a
Bfr1-GFP pull-down, whereas OSH7 was even more en-
riched in GFP-Khd1p pull-downs than by Bfr1-GFP pull-
downs (Fig. 3B). Importantly, ERG4 enrichment is lost in
the bfrmut6A mutant, supporting the idea that this mRNA
is a direct target of Bfr1p.
We have previously shown that RBPs like She2p (Schmid
et al. 2006; Fundakowski et al. 2012) or Khd1p (Syed et al.
2018) are required for ER localization of bound mRNAs.
Because Bfr1p colocalizes with ER and ERG4 encodes a
membrane protein that is supposed to be synthesized
from an ER-associated mRNA, we next tested whether
the loss of BFR1 interferes with ER association of ERG4.
ERG4 mRNA was tagged with 12 MS2 stem–loops using
the recently published improved MS2-tagging system
(Tutucci et al. 2018) and localization of the mRNA was fol-
lowed by coexpression of a GFP-MCP (MS2 coat protein)
fusion protein. ER was detected by a fusion of the trans-
membrane domain of Scs2p (Scs2-TMD) and 2× RFP
(Loewen et al. 2007). In the majority of wild-type cells
(86.6 ± 3.6%) and cells lacking BFR1 (84±2.6%), ERG4-
MS2 RNA particles were detected at or very close to the
ER marker (Fig. 3C,D), indicating that Bfr1p is not required
for ER association of ERG4 mRNA.
Synthesis of the sterol reductase Erg4p depends
on Bfr1p
In parallel to the RNA localization experiments, we wanted
to determine if the loss of BFR1 impacts Erg4 protein local-
ization. The C-24(28) sterol reductase Erg4p is a seven-
transmembrane domain protein that catalyzes the final
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step of ergosterol biosynthesis in the yeast ER (Zweytick
et al. 2000). Consistent with previous observations, a car-
boxy-terminal fusion of Erg4p with yeast enhanced GFP
(yeGFP) colocalizes with an ER marker (HDEL-DSRED;
Bevis and Glick 2002), predominantly with perinuclear ER
(Fig. 4A). Although mRNA localization is unaffected, the
protein level appears to be drastically reduced and no
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FIGURE 2. Bfr1p-associated phenotypes are independent of Bfr1p–RNA interactions. (A) Flow cytometry analysis of Bfr1p variants showing that
ploidy is not changed by themutations in RNA-binding residues of Bfr1p. Histograms show plots of DNA content after propidium iodide staining.
(B) Brefeldin A sensitivity of erg6Δ is rescued by overexpression of wild-type Bfr1p and RNA-binding mutants. Bfr1p mutants (bfr1mut5A: R38A,
K138A, F211A, Y225A, F239A; bfr1mut4A: R38A, K138A, F211A, F239A; bfr1mut3A: R38A, K138A, F239; bfr1mut2A: K138A, F239A) were ex-
pressed from YEplac181 (LEU2) plasmids in cells deleted for BFR1 (bfr1::HIS3MX6) and ERG6 (erg6::KanMX4). Wild-type and erg6Δ cells with
empty YEplac181 plasmids served as controls. Logarithmically growing cells were serially diluted, plated on dropout (-leucine) agar with or with-
out 50 µg/mL brefeldin A, and grown for 72 h at 30°C. (C ) Premature P-bodies are not induced by RNA-binding mutations of Bfr1p. Images were
collected from logarithmically growing cells in dropout media lacking uracil that are shifted for 30 min to media with or without glucose to induce
P-bodies. Plasmid-expressed Edc3p-mCherry serves as P-body marker. Unlike a BFR1 deletion, neither RNA-binding mutations nor Bfr1p(1–397)
show any P-body foci in cells growing in glucose-containing medium. Scale bar, 5 µm.
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However, the RNA-bindingmutant of Bfr1p rescues the ex-
pression of Erg4p. Reduction in Erg4-yeGFP is not due to
increased vacuolar protein degradation since deletion of
PEP4, and encoding a major vacuolar peptidase does
not rescue this phenotype (Fig. 4A). To determine whether
Erg4p is expressed at low levels or not at all, cell lysates
were fractionated to enrich for membrane and cytosolic
fractions. Western blot analysis shows a weaker expression
of Erg4-yeGFP in bfr1Δ cells as compared to wild type and
a shift in its distribution from the membrane to the cytosol-
ic fraction (Fig. 4C). Although bfr1Δ
yeast shares several phenotypes with
scp160Δ cells, including an increase
in ploidy and premature P-body for-
mation, deletion of SCP160 does not
affect Erg4p protein localization (Fig.
4A, lower panels). This suggests that
the observed low expression of
Erg4p is specific to cells lacking Bfr1p.
Proteins that are misfolded at the ER
aremodifiedby theubiquitin-protein li-
gase Hrd1p to facilitate their retranslo-
cation to the cytoplasm and
degradation by the 26S proteasome
in the ERAD (ER-Associated Degrada-
tion) pathway (Hampton 2002; Bal-
dridge and Rappaport 2016). Because
ERG4mRNA is translatedat theER, po-
tentially misfolded Erg4p could be de-
graded by this pathway in bfr1Δ cells.
We, therefore, generated a strain with
a double deletion in BFR1 and HRD1
(bfr1Δ hrd1Δ) expressing Erg4p-
yeGFP. We then blocked 26S protea-
some function using MG132 and pre-
pared cell lysates before or after
blocking translation (30 and 60 min)
by adding CHX. In western blots, we
observed an increased accumulation
of Erg4p upon MG132 treatment in
bfr1Δ and bfr1Δ hrd1Δ cells, but the
increase was much larger in the dou-
ble deletion. This suggests that
Erg4p is misfolded in cells lacking
Bfr1p and targeted by the ERADpath-
way (Fig. 4D). Thus, Bfr1p might help
in proper translocation of Erg4p into
the ER.
Bfr1p affects polysome
association of ERG4 mRNA
Because Bfr1p has been shown to as-
sociate with polysomes (Lang et al.
2001), we decided to test if Bfr1p
directly interacts with ribosomes and if its interaction
with mRNA occurs during translation. For this, we per-
formed coimmunoprecipitation of a yeGFP-tagged Bfr1p
and ribosomes, using the ribosomal small subunit protein
Rps3p as a proxy.We found no evidence for Bfr1p to coim-
munoprecipitate ribosomes (Fig. 5A, IP) and conclude that
the interaction, if any, can only be weak or transient.
We next investigated if the loss of BFR1 or mutations in
its RNA-binding sites result in changes of translation of




FIGURE 3. Bfr1p is not required for the association of ERG4 mRNA with ER. (A) Mutations in
RNA-binding sites in Bfr1p do not affect target mRNA levels. Quantification of mRNA levels of
IMH1, RUD3, ERG4, OSH7, and SGM1 by qRT-PCR. Data are presented as mean values from
three independent experiments with ±SD. (B) ERG4 mRNA binding is strongly affected in
bfr1mut6A. RNA binding of full-length Bfr1p (FL wild type), Bfr1p(1–397), and bfr1mut6A is as-
sessed by coimmunoprecipitation of ERG4 and OSH7 mRNAs and qRT-PCR. MID2 mRNA
serves as a nontarget for Bfr1p. Data are presented as mean values from three biological
and two technical replicates, each with ±SD. (C ) ERG4mRNA association with ER is indepen-
dent of Bfr1p. Representative images of cells expressing MS2-tagged ERG4 mRNA in wild-
type and bfr1Δ. Scs2-TMD-2× RFP serves as an ER marker. White arrows indicate ERG4
mRNA particles. Scale bar, 8 µm. (D) Quantification of ERG4 mRNA colocalization with ER in
wild type and bfr1Δ. Data are presented as mean values from at least 100 cells from three bi-
ological replicates with ±SD.
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purification in combination with mRNA detection by qRT-
PCR (Hirschmann et al. 2014). Ribosomes and bound
mRNAs were affinity-purified from CHX-treated cells via
a TAP-tagged ribosomal Rpl16a protein. The level of ribo-
some-associatedOSH7, ACT1, andMID2mRNAs in bfr1Δ
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FIGURE 4. Bfr1p controls Erg4p expression and distribution. (A) Erg4p distribution changes upon deletion of BFR1. Representative images of
cells from wild-type, bfr1Δ, bfr1mut6A, bfr1Δ pep4Δ, and scp160Δ strains. HDEL-DsRed serves as an ER marker. Scale bar, 5 µm. (B) Western
blot showing down-regulation of Erg4p in bfr1Δ and bfr1mut6A compared to wild type. Total cell lysates were prepared from wild-type,
bfr1Δ, and bfr1mut6A cells expressing a yeGFP-tagged Erg4p protein and Erg4p detected by an anti-GFP antibody. (C ) Erg4p shifts from ER
to cytoplasm in bfr1Δ cells. Western blot following subcellular fractionation of wild-type and bfr1Δ cells expressing yeGFP-tagged Erg4p. (I) input,
(M) membrane fraction, pellet 18,000g, and (C) cytoplasmic fraction, supernatant 18,000g. Pgk1p and Sec61p serve as a cytoplasmic or ER mark-
er, respectively. (D) Representativewestern blot showing accumulation of Erg4p in an ERADmutant upon treatment withMG132. Total cell lysates
were prepared from bfr1Δ and bfr1Δ hrd1Δ cells expressing yeGFP-tagged Erg4p. Cells were harvested at 0, 30, and 60 min after adding cyclo-
heximide (CHX). Pgk1p served as a loading control. The asterisk indicates an unspecific band at 55 kDa detected by the GFP antibody.
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indicating that their ribosomal occupancy is independent
of Bfr1p. In contrast, the amount of ribosome-associated
ERG4 is reduced. Because this method cannot distinguish
between monosome- or polysome-associated mRNAs, we
applied polysome fractionation and determined the distri-
bution of mRNAs between monosomes and polysomes,
which can serve as a proxy for the translational efficiency
of a givenmRNA. Ribosome distribution between fractions
containing free ribosomal subunits, monosomes, or poly-
somes is similar in wild-type, bfr1Δ,
and bfr1mut6A cells, as judged by
the polysome/monosome ratio of
18S rRNA (Fig. 5C) or polysome pro-
files (Fig. 5D). In contrast, significant
changes were seen for the distribution
of ERG4 (P<0.0299) and OSH7 (P<
0.0178) between polysomes and
monosomes when comparing wild-
type cells and cells expressing the
Bfr1p mutant bfr1mut6A. We also ob-
served changes in the distribution of
the control mRNA MID2, although
with low significance (P<0.0708).
Polysome profiles show ERG4 and
OSH7 mRNAs are increased in poly-
somes of bfr1mut6A compared to
wild-type cells. Although this might
suggest a better translation, which is
in contrast to protein expression (Fig.
4B). This apparent discrepancy might
be due to the presence of ERG4 and
OSH7 mRNAs on stalled ribosomes
or improper translocation of the pro-
teins in bfr1 mutants. A similar obser-
vation has been made in the case of
Scp160p in which at least one of its
target mRNAs, PRY3, is increased in
polysomes in cells lacking Scp160p,
whereas Pry3 protein expression is re-
duced (Hirschmann et al. 2014).
DISCUSSION
The yeast RBP Bfr1p has been impli-
cated in various cellular functions,
ranging from control of SPB duplica-
tion to P-body formation. Because
Bfr1p binds to several hundred
mRNAs and is found in the polysome
fraction during sucrose gradient cen-
trifugation, the multiple phenotypes
associated with loss of BFR1might re-
sult from a function in translation or
translation regulation. To establish ad-
ditional evidence for thismodel and to
investigate if the loss of RNA binding is causing the report-
ed phenotypes associated with BFR1 deletion, we studied
the consequences of mutations in documented RNA-bind-
ing sites (Kramer et al. 2014). The mutated amino acids are
conserved between several yeast species and are located
in the first and second coiled-coil domain of Bfr1p as well
as in the region connecting these two coiled-coils. Conver-
sion of six of these RNA contact sites to alanines
(bfr1mut6A) results in loss of the mRNA binding capacity
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FIGURE 5. Bfr1p is required for efficient translational elongation of ERG4 mRNA. (A) Bfr1p
does not coprecipitate the small ribosomal subunit protein Rps3p indicating Bfr1p interaction
with ribosomes is unstable. A representative image of three independent experiments from
Bfr1p-yeGFP immunoprecipitations. (I) Input, (IP) immunoprecipitation, (FT) flowthrough. (B)
Ribosomal occupancy of ERG4 mRNA is reduced in the absence of Bfr1p. Ribosome affinity
purification (RAP) followed by qRT-PCR was performed to measure the ribosome association
of ACT1, ERG4, OSH7, and MID2 mRNAs in wild-type and bfr1Δ cells. An untagged (mock)
strain was used to normalize the data. Quantification graphs show percentage of occupancy
in bfr1Δ to the wild-type levels in three biological and two technical replicates of each with
±SD. (C ) Polysome association of ERG4mRNA changes in bfr1mut6A and bfr1Δ. Sucrose den-
sity gradient fractionation was used to separate monosomes and polysomes, and RNAs from
the fractions were quantified by qRT-PCR. Results are displayed as the fold change ratio of
polysomes/monosomes for four mRNAs (normalized to ACT1 levels) from three independent
experiments with ±SD. An asterisk indicates P<0.05. (ns) Nonsignificant. (D) Polysome profiles
from bfr1mut6A and bfr1Δ compared to wild-type cells. (M) monosomes, (P) polysomes.
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as shown for ERG4mRNA. As a consequence, the ER local-
ization of Bfr1p is lost and the protein redistributes to the
cytoplasm. This suggests that Bfr1p is targeted to ER in a
piggyback manner via bound mRNAs that are translated
at the cytoplasmic face of the ER. Among the six conserved
RNAcontact sites, phenylalanine 293 seems to be themost
critical because the loss of ER association can also be seen
for the F293A mutation. Surprisingly, although ER associa-
tion is lost in these mutants, none of the other described
phenotypes that have been described for bfr1Δ cells can
be detected (Jackson and Képès 1994; Simpson et al.
2014; Weidner et al. 2014). Cells expressing bfr1mut6A
do not show loss of ploidy control and stay haploid. Like
wild-type BFR1, overexpression of bfr1mut6A can fully res-
cue anerg6Δmutantwhenexposed tobrefeldinA (Jackson
and Képès 1994). Finally, unlike bfr1Δ cells, cells express-
ing the RNA-binding mutant do not show a premature for-
mationof P-bodies in unstressed cells (Weidneret al. 2014).
Thus, RNA binding does not seem to be important for
Bfr1p’s functions in ploidy control, repression of P-body
formation, or brefeldin A resistance. Similarly, the third
coiled-coil domain of Bfr1p, which does not contain any
identified RNA contact site, is also dispensable for control-
ling P-body formation and ploidy. This suggests that these
functions of Bfr1p are associated with its amino-terminal
section but might be mediated by protein–protein rather
than protein–RNA interactions.
A large fraction of Bfr1p target mRNAs encodes proteins
translated at the ER (Lapointe et al. 2015). Several RBPs
have been described that participate in or mediate
mRNA association with the ER independent of translation
or SRP-mediated targeting (Cui and Palazzo 2014). These
include mammalian p180 and Kinectin (Cui 2012) and
the yeast RBPs She2p (Schmid et al. 2006) or Khd1p
(Syed et al. 2018). In contrast to these, Bfr1p is not required
for ER localization of at least one of its bound mRNAs,
ERG4. In this respect, it mimics Scp160p, with which it
shares its polysome association and ER colocalization.
Although not necessary for mRNA localization, Bfr1p is re-
quired for the proper translation of the encoded Erg4 pro-
tein, which is consistent with its binding to translating
polyribosomes (Fig. 5A,B; Lang et al. 2001). Not only is
the total amount of Erg4 protein lower in bfr1Δ cells but
the distribution of thismembrane protein is altered and en-
riched in the cytosol rather than the membrane fraction.
Erg4p catalysis is the final step of ergosterol synthesis
from 5,7,22,24(28)-ergostatetraenol to ergosta-5,7,22-
trien-3beta-ol. However, despite the observed alteredpro-
tein distribution, we have not detected changes in the er-
gosterol level of bfr1Δ cells versus wild-type cells. It is
thus likely that the remaining amounts of properly translat-
ed and targeted Erg4p suffices for ergosterol synthesis.
Concomitant with a postulated role of Bfr1p in the trans-
lation of ERG4mRNA, we also observed a decrease of the
fraction of ERG4 mRNA that copurifies with ribosomes.
Surprisingly, the ratio of ERG4mRNA on polysomes versus
monosomes increases, which is apparently contradictory
to the findings of reduced translation. However, a similar
observation has been made for cells lacking the conserved
RBP Scp160p, although for a different set of mRNAs
(Hirschmann et al. 2014). The reduced association of cer-
tain tRNAs with translating ribosomes in cells lacking
Scp160p has led to the model that Scp160p is required
for efficient translation of specific mRNA subsets and that
its loss results in pausing or stalling of ribosomes on
mRNAs (Hirschmann et al. 2014). We envision that Bfr1p
might function similarly to Scp160p but might be impor-
tant for regulating a different set of mRNAs encoding
membrane or secreted proteins at ER.
MATERIALS AND METHODS
Yeast strains and plasmids
Generation of yeast strains and plasmids used in this study as well
as general methods including cell lysis and subcellular fraction-
ation are described in Supplemental Methods.
Confocal microscopy
In vivo imaging of fluorescent labeled proteins was carried
out from inoculation of single colonies into SC or SDC medium
containing 2% glucose and overnight growth at 30°C.
Logarithmically growing cells were harvested and resuspended
in 100 µL of fresh medium. Cells were spread on thin agarose
pads containing SC or SDC with 2% glucose and grown for 30
min at 30°C before observing in the microscope (ZEISS
AxioExaminer equipped with a CSU spinning disc confocal unit;
Visitron Systems). Images were acquired with a 63× oil objective
using VisiView software (Visitron Systems). Post-image processing
was performed using Fiji software as described in Syed et al.
(2018) and Hermesh et al. (2014). For ERG4 mRNA localization,
images were acquired, with each containing at least 60 cells.
For P-body analysis, logarithmically growing cells were harvested,
washed once with sterile water, and then cells were spread on
agarose pads containing SDC medium without glucose and
grown for 30 min at 30°C to induce P-bodies.
Coimmunoprecipitations
For protein–mRNA coprecipitations, experiments were per-
formed as described in Syedet al. (2018) with the following chang-
es. One hundred OD600 units of cells were harvested and
resuspended in 8–10 µL/OD600 of lysis buffer (10 mM Tris-HCl
pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.1% Triton X-100, 1×
Protease inhibitor cocktail and 0.5 U/µL Ribolock RNase inhibitor).
Glass bead lysis was performed and cell debris was removed by
5 min centrifugation at 5000g at 4°C. Protein concentrations
were measured and 200 µg of lysates were subjected to immuno-
precipitation with GFP-Trap_MAmagnetic beads (Chromotek) for
2 h at 4°Con a rotatingwheel. Thebeadswereblockedprior to the
immunoprecipitations with blocking buffer (10 mM Tris-HCl pH
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7.5, 150 mM NaCl, 2 mM EDTA, 0.1% Triton X-100, 0.1 mg/mL
Escherichia coli tRNA and 0.4 mg/mL Heparin). Captured beads
were washed 3× with 500 µL of wash buffer (10 mM Tris-HCl pH
7.5, 150mMNaCl, 2mMEDTA, and 0.1%TritonX-100) and resus-
pended beads with 125 µL of HPLC-grade water (Sigma-Aldrich).
Seventy-fivemicroliters of the bead slurry was used for SDS-PAGE
and western blotting. RNA extraction was carried out with the re-
maining 50 µL of beads, to which 50 ng of spike RNA (in vitro tran-
scribedArabidopsis phosphoribulo kinase RNA) had been added.
For extraction 5 µL of 3 M sodium acetate pH 5.2, 2.5 µL of 20%
SDS and 50 µL of phenol/chloroform/isoamylalcohol (PCI) pH
4.5 was added and the mixed sample centrifuged at maximum
speed for 30 min at 4°C. Nucleic acids were precipitated over-
night at−80°Cwith 20 µg of glycogen and 100 µL of 96% ethanol,
and RNA was resuspended in 20 µL of RNase-free water before
continuing with cDNA synthesis and qPCR.
For coimmunoprecipitation of Rps3p, captured beads were
washed 3× with 500 µL of wash buffer, and bound proteins
were eluted by adding 1× SDS sample buffer to the beads and
boiled for 5 min at 95°C and proceeded with SDS-PAGE and
western blot analysis.
RNA extraction, RT-PCR, and qRT-PCR
Total RNA was extracted from 20 OD600 units of yeast strains
RJY358 and RJY4626. Glass beads lysis was performed in 500
µL of Cross buffer I (0.3 M NaCl, 10 mM Tris-what pH 7.5, 1 mM
EDTA, 0.2% SDS) and 400 µL of phenol:chloroform:isoamylalco-
hol by four pulses of 120 sec with breaks of 60 sec on ice. After
centrifugation for 30 min at full speed, the upper phase was trans-
ferred to a new tube and nucleic acids precipitated with ethanol
for 30 min at −20°C. Total RNA pellets were washed and resus-
pended in 20 µL of HPLC-grade water before proceeding to
cDNA synthesis and qPCR.
Reverse transcription reactions for all the experiments were
performed as described in Syed et al. (2018) with some modifica-
tions. In brief, 1 µg of RNA samples were treated with RQ1 DNase
(Promega), and reverse transcription reactions were performed
using the High-Capacity cDNA Reverse Transcription Kit
(Applied Biosystems). Quantitative RT-PCR (qRT-PCR) was per-
formed in 10 µL reactions containing 2.5 µL of cDNA samples at
1:25 or 1:50 dilutions. Target-specific primers were designed
with Primer3 software (Rozen and Skaletsky 2000). All reactions
were performed from a minimum of three biological replicates
and two technical replicates of each. Quantification was per-
formed by the comparative ΔΔCt method (Livak and Schmittgen
2001; Syed et al. 2018), and values were normalized via the
spiked-in RNA or via ACT1 mRNA signals. For the RT-PCR reac-
tions after RNAse treatment, a PCR reaction with 1 µL of cDNA
with dilutions up to 1:1000 was performed using Taq DNA
polymerase (Genaxxon Bioscience). PCR was performed for 18
cycles using primers specific to 18S rRNA and ERG4 mRNA,
and amplified products were separated by 1% agarose gel
electrophoresis.
Ribosome affinity purifications (RAP-IP)
Ribosome affinity purification (RAP-IP) to determine ERG4 and
OSH7 mRNAs bound to ribosomes was performed as described
in Hirschmann et al. (2014). For the quantifications of mRNAs
bound to the ribosomes, qRT-PCR was performed, and the en-
richment of mRNAs was determined using the ΔΔCT method.
An enrichment of mRNAs from TAP purification (in wild-type
and bfr1Δ) was considered only if at least twofold greater than
frommock purification (strains without TAP tags). The percentage
ribosomal occupancy of bfr1Δ was then plotted against wild-type
levels for the ACT1, ERG4, MID2, and OSH7 mRNAs (Fig. 5C).
Brefeldin A sensitivity drop assay
A single colony of yeast cells was inoculated and grown overnight
before diluting it into fresh medium to grow until logarithmic
phase. Cells were harvested and washed once with sterile water.
One OD600 unit of cells was used for serial dilution and 3 µL of di-
lutions were plated on SDC-leumediumwith or without 50 µg/mL
of brefeldin A (eBioscience). Cells were grown for 72 h at 30°C.
Ploidy analysis by flow cytometry
Cells were prepared for flow cytometry analysis as described
(Baum et al. 2004; Hirschmann et al. 2014). Propidium iodide fluo-
rescence was detected in a Beckman Coulter CytoFlex LX system
with a 675/30 nm filter. Data were analyzed using CytExpert soft-
ware (Beckman Coulter), and representative graphs were plotted
manually using values obtained from the software.
Proteasome inhibition by MG132
To block the proteasomes, we have used commercially available
proteasome inhibitor MG132 (Sigma-Aldrich) and permeabilized
into the cells as described in Liu et al. (2007). Briefly, single colony
cells were inoculated overnight in a synthetic medium containing
0.17% yeast nitrogenous base without ammonium sulfate and
supplemented with 0.1% proline, appropriate amino acids, and
2% glucose as the carbon source. Cultures were reinoculated
in fresh 30 mL media with 0.003% of SDS for 3 h at 30°C. Then
75 µM MG132 dissolved in DMSO or DMSO alone as a control
was added to the cultures and grown for 30 min at 30°C before
adding 100 µg/mL of CHX to the cultures to stop the translation.
Cells were harvested at 0, 30, and 60min and proceeded with cell
lysis and western blot to analyze the protein levels.
Polysome profiling
Separation of mono and polysomes was done as described in
Mittal et al. (2017) and performed with three biological replicates
of wild-type, bfr1Δ, and bfr1mut6A strains. Logarithmically grow-
ing cells were treatedwith 100 µg/mLCHX for 1min, harvested by
vacuum filtration, and flash-frozen with liquid nitrogen. Cells lysis
was performed under cryogenic conditions using lysis buffer (20
mM Tris-HCl, pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1% Triton
X-100, 0.5 mM DDT, and 100 µg/mL of CHX) and a bead mill
(Spex Inc.). Cell debris was removed by centrifugation for 3 min
at 3000g and 4°C followed by 10,000g for 5 min at 4°C. To sep-
arate monosomes and polysomes, 10 A260 units of lysates were
loaded on precooled 12 mL of 7%–47% linear sucrose gradients
(50 mM Tris-HCl, pH 7.5, 50 mM NH4Cl, 12 mM MgCl2, 0.5 mM
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DTT, and 100 µg/mL CHX) and centrifuged at 35,000 rpm for 3 h
at 4°C in a TH-641 rotor (Thermo Scientific) before collecting the
monosome and polysome peaks (Fig. 5D). RNA was isolated by
adding 5 µL of glycogen and phenol:chloroform (5:1) before reex-
traction of the aqueous phase with chloroform and precipitation
in ethanol overnight at −20°C. RNA pellets were resuspended
in 30 µL of HPLC-grade water and processed for cDNA synthesis
and qRT-PCR.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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